Trademark Overview
On Wednesday, February 5, 2025, a trademark application was filed for XALPHAMIT with the United States Patent and Trademark Office. The USPTO has given the XALPHAMIT trademark a serial number of 99029911. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 5, 2025. This trademark is owned by RayzeBio, Inc.. The XALPHAMIT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations.